Clinical Whitepaper

High-Level Disinfection for Ophthalmic Instruments and Eyedropper Bottles

A clinical whitepaper for ophthalmology, optometry, and ophthalmic surgery practices. Saniteyes™ UVC Disinfection System by Dropmate Inc.

≥6-log

Bacterial & fungal reduction
in 5 minutes

≥4-log

Viral reduction including Adenovirus Type 5

1,300+

PMMA cycles with zero structural degradation

The Disinfection Gap

The Disinfection Gap in Ophthalmic Practice

Tonometry is performed on virtually every patient in an ophthalmic clinic. The Goldmann applanation tonometer prism is classified as a semi-critical instrument requiring high-level disinfection (HLD) between patients. In practice, the dominant method — an IPA wipe — does not achieve HLD and has been directly linked to adenoviral transmission.

Disinfection Method

HLD Compliant

Key Limitations

70% Isopropyl Alcohol Wipe

No

Ineffective against non-enveloped viruses (adenovirus, EKC). Degrades PMMA prisms. Contact time insufficient.

Chemical Soaking (NaOCl, H₂O₂)

Conditional

Causes structural damage to PMMA with repeated use. Requires rinsing. Risk of iatrogenic keratopathy. Impractical for high throughput.

UV-C Germicidal Irradiation (Saniteyes™)

Yes

Validated ≥6-log bacterial/fungal, ≥4-log viral reduction in 5 min. No residue, no instrument damage through 1,300+ cycles. Fully automated.

Instrument Degradation Under Chemical Protocols

PMMA tonometer prisms and diagnostic contact lenses are precision instruments with significant replacement costs. Repeated chemical disinfection causes measurable degradation in optical clarity and surface microstructure. In contrast, PMMA prisms subjected to 1,300+ Saniteyes™ cycles — simulating approximately five years of clinical use — showed no detected cracks, fissures, or biomechanical changes.

The Compliance Problem

Even theoretically adequate protocols are undermined by real-world variability. Chemical soaking requires preparation, timing, and rinsing steps that create friction in high-volume workflows. Staff turnover and inconsistent training produce a disinfection standard that exists on paper but not reliably in practice. Automated UVC disinfection removes operator technique as a variable — the same validated cycle on every use.

Eyedropper Bottles

The Eyedropper Bottle as an Overlooked Vector

Multi-dose eyedropper bottles are used in every ophthalmic clinic. These bottles are handled by staff, touched by multiple patients, and recapped repeatedly. Unlike tonometer tips, their disinfection is rarely considered, and most clinics have no established protocol for it.

Clinical Setting

Contamination Rate

Primary Organisms

Home use (glaucoma patients)

5% – 70%

Staphylococcus, Corynebacterium, Bacillus

Outpatient clinics

17% – 30%

Coagulase-negative Staphylococci, Micrococcus

Operating theatre (perioperative)

2% – 5%

S. hominis, S. epidermidis

Preservative-free multi-dose bottles

8% – 19%

S. aureus, Serratia, Klebsiella

Iatrogenic Ocular Dysbiosis

Low-grade, persistent inflammation caused by clinic-acquired microbial dysbiosis is frequently attributed to the patient's underlying condition or medication side effects. Contaminated instruments and shared bottles may represent an underrecognized driver of patient dissatisfaction, treatment failure, and poor online reviews related to redness, burning, or irritation following clinical visits.

Ocular Microbiome

The Ocular Surface Microbiome and Dysbiosis

The healthy ocular surface maintains a low-biomass microbiome critical for immunity, pathogen exclusion, and tear film stability. When contaminated instruments or drops repeatedly introduce non-commensal bacteria, the result is ocular dysbiosis — a shift toward pro-inflammatory profiles.

Condition

Dysbiosis Mechanism

Clinical Relevance

Dry Eye Disease (DED)

Elevated inflammatory cytokines alter tear film osmolarity; selects for S. aureus overgrowth

Self-perpetuating cycle worsened by contaminated drops and BAK exposure

Meibomian Gland Dysfunction (MGD)

C. acnes overgrowth produces lipase that destabilizes tear film lipid layer

Burning, stinging, foreign body sensation often misattributed to medication

Pre-surgical OSM disruption

Dysbiosis primes conjunctiva for fibrotic response

Increased risk of bleb failure, pterygium recurrence, graft rejection

Post-surgical vulnerability

Prophylactic antibiotics reduce OSM diversity for 2–4 weeks

Opportunistic pathogen colonization during immune-compromised recovery

EKC & clinic outbreaks

Adenovirus resistant to IPA; transmitted via tonometer and instruments

Clinic closures, patient harm, liability exposure, reputational damage

The Paradox of Prophylaxis

Standard perioperative antibiotic regimens reduce OSM diversity at 2 and 4 weeks post-operation, creating a vulnerability window. Using UVC-disinfected eyedropper bottles during this period ensures post-operative management does not inadvertently introduce pathogens onto an already-compromised ocular surface.

Saniteyes™ System

Saniteyes™ High-Level Disinfection System

The first FDA-registered, automated point-of-care UVC disinfection device purpose-built for semi-critical ophthalmic instruments. UVC induces pyrimidine dimer formation in microbial DNA/RNA — no chemical residue, no instrument damage, no opportunity for resistant strain selection.

Wavelength

254–280 nm (germicidal spectrum)

HLD Standard

≥6-log bacterial/fungal; ≥4-log viral

Cycle Time

5 min (standard) · 10 min (extended)

Capacity

3 independent bays

Dose Verification

Photochromic strips + electronic dosimeters

Compatible Instruments

Tonometer prisms, diagnostic lenses, laser lenses, eyedropper bottles, iCare probes

Regulatory Status

FDA-registered Class I medical device

Instrument Durability

>1,300 cycles, no degradation; LEDs rated 10,000+

Efficacy Against Clinically Relevant Pathogens

Staphylococcus aureus

Gram-positive

Blepharitis, keratitis, post-op infections

≥6-log

Pseudomonas aeruginosa

Gram-positive

Corneal ulcers; MDR strains in artificial tear outbreaks

≥6-log

Candida albicans

Fungus

Fungal keratitis, endophthalmitis

≥6-log

Mycobacterium terrae

Mycobacterium

HLD indicator organism; TB analog

≥6-log

Adenovirus Type 5

Non-enveloped virus

Primary agent of EKC; resistant to IPA

≥4-log

Bovine Coronavirus

Enveloped virus

Indicator for SARS-CoV-2 and respiratory viruses

≥4-log

Medication and Material Safety

UVC wavelengths cannot penetrate standard LDPE or glass ophthalmic bottles. The chamber orients the LED array to saturate the nozzle exterior while preventing irradiation from entering the bore. No rinsing required before patient use. No extractables or leachables introduced into the medication. Staff are never exposed to UV-C during normal operation via fully enclosed design with safety interlocks.

Implementation

Clinical Implementation

Tonometry & Diagnostic Instruments

Run a 5-minute cycle between every patient encounter. With one unit per exam lane and two prisms per lane (one in use, one cycling), throughput is not disrupted.

Stanford Health Care currently operates the system across 40 exam lanes, with no citations from The Joint Commission or DNV at institutions using the device.

Multi-Dose Clinic Bottles

Shared bottles including proparacaine, tetracaine, tropicamide, phenylephrine, and fluorescein represent the highest-risk vectors for cross-contamination.

Implementation requires placing the bottle in the device between encounters — a workflow step standardized at the slit lamp or exam lane.

Economic & Sustainability Impact

$3K–$10K

Annual savings on chemical
disinfectant consumables

100+ kg

Plastic waste reduction
per department annually

$50K–$150K

Total estimated annual savings
for larger practices

Recommendations

Recommendations for Clinical Practice

Immediate Protocol Updates

1

Replace alcohol-wipe protocols for tonometer tips with automated UVC disinfection between every patient to achieve validated HLD and eliminate EKC transmission risk.

2

Implement UVC disinfection for shared multi-dose clinic bottles (proparacaine, tropicamide, phenylephrine, fluorescein) between patient encounters.

3

Designate post-operative bottle management as an infection control priority. Use UVC-disinfected delivery systems during the 4-week post-surgical vulnerability window.

4

Document disinfection for semi-critical instruments using Saniteyes™ indicator strips and cycle logs to support OSHA and AAMI compliance.

Patient Communication

4

Counsel chronic drop users (glaucoma, DED) that contamination-driven dysbiosis may be contributing to persistent symptoms misattributed to medication side effects.

5

Provide clear bottle hygiene education including tip-to-lid contact risk, replacement intervals (30–60 days), and home disinfection options for high-risk patients.

6

Consider dysbiosis as a differential in patients with worsening redness, burning, or dry eye symptoms that correlate with prolonged use of a single multi-dose bottle.

References

1.

Shankar V, Shukla A, Ianchulev P, et al. Efficacy of an Automated Point-of-Care UVC Disinfection System for Reusable Ophthalmic Devices. Ophthalmology. 2026. doi:10.1016/j.ophtha.2025.12.032

2.

Kugadas A, Gadjeva M. Impact of Microbiome on Ocular Health. Ocul Surf. 2016;14(3):342-349.

3.

Dong Q, et al. Diversity of Bacteria at Healthy Human Conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408.

4.

Tariq F, et al. The Ocular Surface Microbiome in Homeostasis and Dysbiosis. Microorganisms. 2025;13(9):1992.

5.

Dong X, et al. Composition and Diversity of Bacterial Community in Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2019;60(14):4774.

6.

Ozkan J, Willcox MD. The Ocular Microbiome. Curr Eye Res. 2019;44(7):685-694.

7.

Okonkwo A, et al. Next-Generation Sequencing of the Ocular Surface Microbiome. Eye & Contact Lens. 2020;46(4):254-261.

8.

CDC: Outbreak of Extensively Drug-Resistant Pseudomonas aeruginosa Associated with Artificial Tears. archive.cdc.gov.

Pilot Saniteyes at Your Institution

We offer complimentary one-month pilots for academic medical centers, health systems, and high-volume practices.

Request a Pilot